What captures HCPs’ interest?
This is a common question we receive from our clients. As a publishing partner to numerous prestigious medical associations, reaching over 850,000 HCPs each day, we have a wealth of data on what content engages HCPs. So, we decided to take a fresh look at what stories generated the most clicks since the beginning of the year among the below specialty groups.
What patterns emerged?
- First, COVID is no longer the key topic of focus. COVID dominated the consumer and HCP news cycle throughout 2020 and much of 2021. Now, two years into the pandemic, we are seeing HCP content consumption habits have shifted back to a state more akin to the time before the pandemic began for most specialists. However, within the specialties we analyzed, pediatricians remain focused on COVID news. This may be due to children’s unique vulnerability to infectious diseases among the patient population as well as the ongoing vaccine approval processes for children.
- Second, specialty HCP audiences are keen on specific news. This has been a tried-and-true theme throughout the years. Specialist HCP groups are engaging with very specific content that is germane to their specialty. This demonstrates their hunger for relevant, useful clinical information that will help them make the best treatment decisions on a day-to-day basis.
- Finally, broad HCP audiences are interested in a wide variety of topics. Groups such as the American Medical Association span the gamut of medical specialties, resulting in a wide variety of topics of interest. Overall, we’ve found news articles covering topics that touch on a common denominator across these HCP groups are what generate the most interest.
We hope you enjoy this retrospective on what “clicks” with HCPs right now. Check out this space for more insights and don’t hesitate to reach out to us at firstname.lastname@example.org with any questions!
Top Clicked Stories
1. Sunscreens Protecting Against UVA, UVB Light May Provide Only Incomplete Skin Protection, Experts Contend
2. Certain Dilution Of Botulin Toxin May Be Effective Dermatological Treatment For Patients With Mild-To-Moderate Acne Vulgaris, Erythematotelangiectatic Rosacea, Research Suggests
3. Researchers Make Case For Treating Pediatric Longitudinal Melanonychia Differently From Longitudinal Melanonychia In Adults
4. Patients With Hyperpigmentation Disorders May Benefit From Novel Stabilized Formulation Of Topical Cysteamine, Meta-Analysis Indicates
5. Platelet-Rich Plasma Promising For Female Pattern Hair Loss, Study Indicates
1. CDC, AAP Update Developmental Milestones For Infants, Young Children
2. Use Of Nonpharmaceutical Interventions Appears To Decrease COVID-19 Transmission Risk Following High-Risk Exposure, Study Suggests
3. New CDC Guidelines Suggest 70% Of Americans Can Stop Wearing Masks
4. Omicron Variant May Be More Dangerous For Children Than Previous Strains, South African Study Suggests
5. FDA Warns Consumers Not To Use Certain Infant Formula After Recall Due To Bacteria Infections
1. Post-Procedural Anticoagulation After Primary PCI May Improve Survival Rates Among Patients With STEMI, Study Suggests
2. Ross Procedure For Aortic Valve Replacement Tied To Better Long-Term Survival Compared With Biological, Mechanical AVR, Data Indicate
3. New ACC, AHA, HFSA Guideline Redefines HF Stages To Focus On Prevention, Recommends HF Treatment With SGLT2 Inhibitors
4. Compared With Septal Myectomy, Alcohol Septal Ablation For Obstructive HCM May Be Tied To Greater Rate Of 10-Year All-Cause Death, Researchers Say
5. Long-Term Use Of Common Medications For Hypertension May Cause Kidney Damage, Researchers Say
1. Ivermectin does not appear to reduce risk of hospitalization from COVID-19, study finds
2. USPSTF finalizes recommendations on low-dose aspirin regimens for CVD prevention
3. Research: MS severity may be tied to geographic latitude
4. Two-thirds of U.S. water systems have detectable levels of uranium
5. Former Biden health advisers urge administration to adopt new domestic pandemic strategy
1. Genomically Directed Therapy Did Not Improve Outcomes In Patients Who Had Residual Triple-Negative Breast Cancer After Neoadjuvant Chemotherapy, Study Finds
2. Total Neoadjuvant Therapy Approach Could Be An Alternative To Standard Chemoradiotherapy For Patients With Locally Advanced Rectal Cancer, Trial Suggests
3. FDA Grants Breakthrough Therapy Designation To Patritumab Deruxtecan For Treatment Of Certain Individuals With Non-Small Cell Lung Cancer
4. Hormonal Therapy For Advanced Prostate Cancer Had A Significant Association With Cognitive Impairment, Analysis Shows
5. Neoadjuvant Gemcitabine-Based Chemoradiotherapy Improved OS In Patients With Resectable And Borderline Resectable Pancreatic Cancer, Trial Finds